IP litigation and damages

Commercial Success

CRA experts prepare accounting, marketing and economic analyses relevant to Commercial Success, a secondary consideration in the determination of obviousness for patents. We provide clear and fact-supported testimony in all forums where the validity of patents is at issue, including in patent infringement litigation, PTAB IPRs, and in ITC Section 337 investigations. Our experts with deep experience in the pharmaceutical and life science sectors are particularly suited to addressing Commercial Success in ANDA/Hatch-Waxman litigation.


  • 01
    Evaluation of a blockbuster heart failure medication
    On behalf of a plaintiff for a blockbuster heart failure fixed-dose combination medication, CRA was retained to assess the commercial success of the product...
    View engagement
  • 02
    Evaluation of an asthma medication with once-a-day dosing
    In a Hatch-Waxman litigation involving a drug for asthma, CRA’s life sciences experts were asked to assess commercial success and its nexus to the patent. In...
    View engagement
  • 03
    Evaluation of a diabetes treatment
    CRA consultants supported a pharmaceutical company in its successful challenge of an ANDA filed by a generic manufacturer. The generic company sought to...
    View engagement

Contact a Commercial Success expert.

See all Commercial Success experts.

Related capabilities

Subscribe to receive our latest Insights.